Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cardiology | 5 | 2021 | 2873 | 0.75 | Why? |
| Transitional Care | 1 | 2020 | 135 | 0.73 | Why? |
| Cardiovascular Diseases | 6 | 2021 | 11497 | 0.64 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 396 | 0.63 | Why? |
| Pacemaker, Artificial | 1 | 2020 | 431 | 0.58 | Why? |
| Defibrillators | 1 | 2015 | 144 | 0.57 | Why? |
| Patient Transfer | 1 | 2020 | 898 | 0.49 | Why? |
| Cardiologists | 4 | 2020 | 366 | 0.45 | Why? |
| Death, Sudden, Cardiac | 1 | 2015 | 522 | 0.41 | Why? |
| Defibrillators, Implantable | 1 | 2015 | 624 | 0.36 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.36 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.33 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.33 | Why? |
| Acute Coronary Syndrome | 2 | 2020 | 2107 | 0.33 | Why? |
| Risk Assessment | 7 | 2020 | 25439 | 0.32 | Why? |
| Referral and Consultation | 2 | 2020 | 4816 | 0.32 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.31 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.24 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.24 | Why? |
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2020 | 8 | 0.22 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.21 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.21 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.20 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.20 | Why? |
| Role | 1 | 2020 | 266 | 0.19 | Why? |
| Prosthesis Implantation | 1 | 2020 | 261 | 0.17 | Why? |
| Italy | 6 | 2021 | 38444 | 0.17 | Why? |
| Aminobutyrates | 1 | 2018 | 142 | 0.17 | Why? |
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 206 | 0.16 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.16 | Why? |
| Smoking Prevention | 1 | 2017 | 116 | 0.15 | Why? |
| Tetrazoles | 1 | 2018 | 262 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.14 | Why? |
| Cardiac Tamponade | 1 | 2018 | 165 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.14 | Why? |
| National Health Programs | 1 | 2021 | 807 | 0.14 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.13 | Why? |
| Aspirin | 2 | 2018 | 1043 | 0.12 | Why? |
| Healthy Lifestyle | 1 | 2017 | 447 | 0.12 | Why? |
| Pericarditis | 1 | 2018 | 417 | 0.12 | Why? |
| Tachycardia, Ventricular | 1 | 2015 | 251 | 0.12 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.12 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.11 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2018 | 1671 | 0.11 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.10 | Why? |
| Societies, Medical | 3 | 2020 | 6907 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.10 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.09 | Why? |
| Primary Prevention | 1 | 2015 | 778 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.08 | Why? |
| Humans | 16 | 2021 | 930598 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Patient Compliance | 1 | 2015 | 1468 | 0.07 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.07 | Why? |
| Equipment Design | 1 | 2015 | 3095 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2018 | 3892 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Male | 7 | 2020 | 367725 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Female | 7 | 2020 | 380317 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Pulmonary Circulation | 1 | 2020 | 207 | 0.04 | Why? |
| Pericardiocentesis | 1 | 2018 | 84 | 0.04 | Why? |
| Neprilysin | 1 | 2018 | 112 | 0.04 | Why? |
| Contraindications, Drug | 1 | 2018 | 281 | 0.04 | Why? |
| Valsartan | 1 | 2018 | 206 | 0.04 | Why? |
| Biphenyl Compounds | 1 | 2018 | 249 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2018 | 1256 | 0.04 | Why? |
| Hypotension | 1 | 2018 | 392 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.03 | Why? |
| European Union | 1 | 2017 | 565 | 0.03 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Stents | 1 | 2018 | 916 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Aged | 2 | 2018 | 215776 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Middle Aged | 2 | 2018 | 270681 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |
Gabrielli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_